TILT Biotherapeutics
Biotechnology Research • 
Helsinki, Uusimaa, Finland • 21-50 Employees
Company overview
| Headquarters | Tukholmankatu 8B, c/o Biomedicum 2B, Helsinki, 00290, FI |
| Phone number | +35825440205 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Immunotherapy, Cancer, Solid Tumors, Oncolytic Viruses, Oncoimmunology, Immune Checkpoint Inhibitors, T-Cell Therapy |
| Founded | 2013 |
| Employees | 21-50 |
| Socials |
Key Contact at TILT Biotherapeutics
Akseli Hemminki
Chief Executive Officer
TILT Biotherapeutics Email Formats
TILT Biotherapeutics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@tiltbio.com), used 56.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@tiltbio.com | 56.5% |
{first initial} | j@tiltbio.com | 30.4% |
{first name}.{last name} | john.doe@tiltbio.com | 8.7% |
{first name} | john@tiltbio.com | 4.3% |
About TILT Biotherapeutics
TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his past findings in the lab, but more importantly in the clinic. The research conducted by TILT alone or in collaboration with some of world’s leading research groups with synergic technologies has generated very excellent results. The lead candidate is a clinical stage TNFα/IL2 armed oncolytic adenovirus (TILT-123 or Ad5/3-E2F-delta24-hTNFα-IRES-hIL2). Multiple Phase I clinical trials are ongoing. For contact: BD (at) tiltbio.com
TILT Biotherapeutics revenue & valuation
| Annual revenue | $4,000,000 |
| Revenue per employee | $143,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $12,800,000 |
| Total funding | $37,900,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
TILT Biotherapeutics has 12 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore TILT Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.
TILT Biotherapeutics Tech Stack
Discover the technologies and tools that power TILT Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.
Font scripts
CDN
Web servers
JavaScript libraries
Programming languages
Miscellaneous
Blogs
JavaScript libraries
Maps
Databases
Miscellaneous
Performance
United States
Belgium
Germany
Spain
Frequently asked questions
4.8
40,000 users
